Review demonstrates multidrug resistance and rapid spread of Candida auris in immunocompromised individuals, highlighting urgent needs for infection control.
This review offers a multidimensional analysis of Candida auris, a significant fungal pathogen emerg¬ing globally, challenging healthcare systems. Discovered recently, C. auris draws attention due to its rapid spread, multidrug resistance, and high morbidity and mortality rates, particularly in immunocompromised individuals. Its taxonomic classification within the Metschnikowiaceae family sets it apart from common Candida species. We discuss C. auris’s phenotypic traits, including its survival in extreme conditions and unique morphology, and delve into genomic insights like ploidy switching and clade-specific variations. Its epidemiology demonstrates adaptability, with environmental isolates found in diverse ecosystems, in¬dicating broader ecological impacts. The review explores C. auris’s presence in European healthcare en¬vironments, emphasizing its role in nosocomial infections. Diagnosing C. auris is challenging; traditional methods are limited, highlighting the need for advanced molecular diagnostics for accurate identification. A key focus is C. auris’s antifungal resistance, detailing resistance mechanisms to major antifungal classes and efforts toward developing effective treatments. Finally, the review stresses the importance of infection control and prevention strategies in healthcare settings, underscoring the need for comprehensive measures to mitigate the spread of this formidable pathogen.
No takes yet. Share an insight, caveat, or question.
Tsitou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: